[Antimicrobial therapy for patients with HIV infection]

Nihon Naika Gakkai Zasshi. 2006 Nov 10;95(11):2214-9. doi: 10.2169/naika.95.2214.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Antibiotic Prophylaxis
  • Antiretroviral Therapy, Highly Active
  • Antiviral Agents / administration & dosage
  • CD4-Positive T-Lymphocytes
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / economics
  • Cytomegalovirus Infections / prevention & control
  • Diagnosis, Differential
  • HIV Infections / complications*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Infections / immunology
  • Humans
  • Mycobacterium avium-intracellulare Infection / complications*
  • Mycobacterium avium-intracellulare Infection / diagnosis
  • Mycobacterium avium-intracellulare Infection / drug therapy*
  • Mycobacterium avium-intracellulare Infection / prevention & control
  • Opportunistic Infections / complications*
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / prevention & control
  • Pneumonia, Pneumocystis / complications*
  • Pneumonia, Pneumocystis / diagnosis
  • Pneumonia, Pneumocystis / drug therapy*
  • Pneumonia, Pneumocystis / prevention & control
  • Tuberculosis / complications*
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy*
  • Tuberculosis / prevention & control
  • Virus Diseases / complications*
  • Virus Diseases / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents